HAYWARD, Calif., Jan. 5, 2012 /PRNewswire/ -- Molecular diagnostics company GenturaDx announced today that the company will present at the Biotech Showcase Conference on Monday, January 9 at 9:15 a.m. Pacific Time at the Parc 55 Wyndham Hotel in San Francisco.
Mark Bagnall, president and CEO of GenturaDx, will provide an update on the company and the IDbox system. The company is currently in beta studies with clinical trials to start mid-2012.
GenturaDx is a molecular diagnostic company focused on making high-performance molecular diagnostics both affordable and practical for any laboratory to perform. The company is developing a fully integrated, automated instrument that conducts testing using a single-use cassette. This platform will make rapid, high-quality molecular diagnostics accessible to hospitals and patients worldwide circumventing long-standing barriers of costs, automation and performance. GenturaDx's compact, self-contained platform incorporates sample preparation with proprietary, real-time PCR amplification and detection, reducing the risk of contamination and saving time. The platform's unique engineering design and intuitive interface relies on semi-batch processing capability while improving clinical value by offering multiple molecular targets in a single test. For more information, go to www.GenturaDx.com.